Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Featured Practice Guidelines
    • Acute Altitude...

    Acute Altitude Illness: New management guidelines

    Written by Hina Zahid Published On 2019-11-10T19:00:43+05:30  |  Updated On 10 Nov 2019 7:00 PM IST
    Acute Altitude Illness: New management guidelines

    Wilderness Medical Society (WMS) has updated evidence-based guidelines for the prevention and treatment of acute altitude illness. The guideline developed by an expert panel shall provide guidance to clinicians and disseminate knowledge about best practices for the prevention and treatment of acute altitude illness. These recommendations are intended to apply to all travellers to high altitude, whether they are travelling to high altitude for work, recreation, or various activities including hiking, skiing, trekking, and mountaineering. The guidelines have been published in the Journal of Wilderness and Environmental Medicine.


    Travel to elevations above 2500 m is associated with risk of developing 1 or more forms of acute altitude illness: acute mountain sickness (AMS), high altitude cerebral edema (HACE), and high altitude pulmonary edema (HAPE). Because large numbers of people travel to such elevations, many clinicians are faced with questions from patients about the best means to prevent these disorders. In addition, clinicians working at facilities in high altitude regions or as members of expeditions travelling to such areas can expect to see persons who are experiencing these illnesses and must be familiar with prophylactic regimens and proper treatment protocols.


    Following are the major recommendations:





    • Gradual ascent, defined as a slow increase in sleeping elevation, is recommended for AMS and HACE prevention.

    • Acetazolamide should be strongly considered in travellers at moderate or high risk of AMS with an ascent to high altitude.

    • Acetazolamide can be used in children for prevention of AMS.

    • Dexamethasone can be used as an alternative to acetazolamide for adult travellers at moderate or high risk of AMS.

    • Inhaled budesonide should not be used for altitude illness prophylaxis.

    • Ginkgo biloba should not be used for AMS prevention

    • Ibuprofen can be used for AMS prevention in persons who do not wish to take acetazolamide or dexamethasone or have allergies or intolerance to these medications.

    • Acetaminophen should not be used for AMS prevention.

    • When feasible, staged ascent and pre acclimatization can be considered as a means for AMS prevention.

    • Hypoxic tents can be used for facilitating acclimatization and preventing AMS, provided sufficiently long exposures can be undertaken regularly over an appropriate number of weeks and other factors, such as sleep quality, are not compromised.

    • The descent is effective for any degree of AMS/HACE and is indicated for individuals with severe AMS, AMS that fails to resolve with other measures, or HACE.

    • When available, ongoing supplemental oxygen sufficient to raise SpO2 to >90% or to relieve symptoms can be used while waiting to initiate descent or when the descent is not practical.

    • When available, portable hyperbaric chambers should be used for patients with severe AMS or HACE when the descent is infeasible or delayed and supplemental oxygen is not available.

    • Acetazolamide should be considered for the treatment of AMS.

    • Dexamethasone should be considered for the treatment of AMS.

    • Dexamethasone should be administered to patients with HACE.

    • Acetaminophen can be used to treat headache at high altitudes.

    • Ibuprofen can be used to treat headache at high altitudes.

    • Because of lack of data, no recommendation can be made regarding the use of CPAP for AMS treatment.

    • Gradual ascent is recommended to prevent HAPE.

    • Nifedipine is recommended for HAPE prevention in HAPE-susceptible people

    • Salmeterol is not recommended for HAPE prevention.

    • Tadalafil can be used for HAPE prevention in known susceptible individuals who are not candidates for nifedipine.

    • Dexamethasone can be used for HAPE prevention in known susceptible individuals who are not candidates for nifedipine and tadalafil.

    • Because of a lack of data, no recommendation can be made regarding the use of acetazolamide for HAPE prevention.

    • Acetazolamide can be considered for prevention of reentry HAPE in people with a history of the disorder.

    • When feasible, staged ascent and pre acclimatization can be considered as a means for HAPE prevention.

    • The descent is indicated for individuals with HAPE.

    • When available, supplemental oxygen sufficient achieve a SpO2 of >90% or to relieve symptoms should be used while waiting to initiate descent when the descent is infeasible and during descent in severely ill patients.

    • When descent is infeasible or delayed or supplemental oxygen is unavailable, a portable hyperbaric chamber may be used to treat HAPE.

    • Nifedipine should be used for HAPE treatment when the descent is impossible or delayed and reliable access to supplemental oxygen or portable hyperbaric therapy is unavailable.

    • No recommendation can be made regarding beta-agonists for HAPE treatment due to a lack of data.

    • Tadalafil or sildenafil can be used for HAPE treatment when the descent is impossible or delayed, access to supplemental oxygen or portable hyperbaric therapy is impossible, and nifedipine is unavailable.

    • CPAP or EPAP may be considered for the treatment of HAPE when supplemental oxygen or pulmonary vasodilators are not available or as adjunctive therapy in patients not responding to supplemental oxygen alone.

    • Diuretics should not be used for the treatment of HAPE.

    • Acetazolamide should not be used for the treatment of HAPE.

    • Because of insufficient evidence, no recommendation can be made regarding dexamethasone for HAPE treatment.


    DOI: https://doi.org/10.1016/j.wem.2019.04.006

    acetaminophendexamethasonehigh altitude cerebral edemahigh altitude pulmonary edemaibuprofennifedipinepulmonary edemasleeping elevationSupplemental oxygentadalafilWilderness Medical Society
    Source : Journal of Wilderness and Environmental Medicine

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok